Tivozanib in the treatment of renal cell carcinoma
Mehmet Hepgur, Sarmad Sadeghi, Tanya B Dorff, David I Quinn Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA Abstract: Renal cell carcinoma (RCC) is an aggressive malignancy compared to other urological...
Guardado en:
Autores principales: | Hepgur M, Sadeghi S, Dorff TB, Quinn DI |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/242d5852ebca479689281f0fe367f822 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
por: Ansari J, et al.
Publicado: (2013) -
Diagnosis and surgical treatment of renal cell carcinoma with supradiaphragmatic level invasion of the inferior vena cava
por: I.I. Kobza, et al.
Publicado: (2018) -
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
por: Bernard Escudier, et al.
Publicado: (2008) -
PAK5‐stabilized Smuc confers renal cell carcinoma metastasis
por: Fu‐Chun Huo, et al.
Publicado: (2021) -
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
por: Peter E Clark
Publicado: (2010)